Amendment #3 ------------Clinical Study and Research Agreement • February 14th, 2000 • Cistron Biotechnology Inc • In vitro & in vivo diagnostic substances
Contract Type FiledFebruary 14th, 2000 Company Industry
Amendment #1 ------------ By this Amendment, Duke University ("DUKE"), and CISTRON Biotechnology, Inc. ("SPONSOR") agree to amend the terms of the Clinical Study and Research Agreement entered into by the parties effective September 1, 1998,...Clinical Study and Research Agreement • February 14th, 2000 • Cistron Biotechnology Inc • In vitro & in vivo diagnostic substances
Contract Type FiledFebruary 14th, 2000 Company Industry
Amendment #2 ------------Clinical Study and Research Agreement • February 14th, 2000 • Cistron Biotechnology Inc • In vitro & in vivo diagnostic substances
Contract Type FiledFebruary 14th, 2000 Company Industry
November 24, 1998 Mr. Tom Wudarski Office of Research Affairs 1020 Locust Street JAH Room M-5 Philadelphia, Pa. 19107 Dear Tom: By this letter, I would like to formally propose the extension of funding under the Clinical Study and Research Agreement...Clinical Study and Research Agreement • March 31st, 1999 • Avax Technologies Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 31st, 1999 Company Industry